A Single Dose Crossover Study In Healthy Subjects To Evaluate Different Formulations Of PF-06882961

NCT03492697 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: PF-06882961 Immediate Release Tablet
DRUG: PF-06882961 Controlled Release Tablet (long)
DRUG: PF-06882961 Controlled Release Tablet (short)
DRUG: PF-06882961 Immediate Release Solution

Sponsor

Pfizer